The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Basic local alignment search tool

Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432

Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation

Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361

Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases

Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,331

Expression and Subcellular Location of Alpha-Synuclein During Mouse-Embryonic Development

Zhong, S., Luo, X. G., Chen, X.-S., Cai, Q., Liu, J., Chen, X., & Yao, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9473-4 · Cited by 50

Lysines, Achilles’ heel in alpha-synuclein conversion to a deadly neuronal endotoxin

Plotegher, N., & Bubacco, L. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.002 · Cited by 50

Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions

Tanriöver, G., Bacioglu, M., Schweighauser, M., Mahler, J., Wegenast‐Braun, B. M., Skodras, A., Obermüller, U., Barth, M., Kronenberg‐Versteeg, D., Nilsson, K. P. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00993-8 · Cited by 50

- α-Synuclein and Parkinson’s Disease

Gasser, T. (2012) · CRC Press eBooks · doi:10.1201/b12948-15 · Cited by 50

Neuropathology of α‐synuclein in Parkinson's disease

Choong, C., & Mochizuki, H. (2022) · Neuropathology · doi:10.1111/neup.12812 · Cited by 55

The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers

Cristiane, L., Cabral, K. M. D. S., de Oliveira, G. A. P., Raymundo, D. P., de Freitas, J. A., Johanson, L., Romão, L. F., Palhano, F. L., Herrmann, T., Almeida, M. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662254 · Cited by 50

Human α-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1

Lee, H. J., Kang, S. J., Lee, K., & Im, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.028 · Cited by 49

The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson’s disease

Muñoz, S. S., Petersen, D., Marlet, F. R., Kücükköse, E., & Galvagnion, C. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106534 · Cited by 49

Secondary structure and dynamics of micelle bound β‐ and γ‐synuclein

Sung, Y., & Eliezer, D. (2006) · Protein Science · doi:10.1110/ps.051803606 · Cited by 49

Development of a new treatment for alzheimer’s disease and parkinson’s disease using anti-aggregatory β-synuclein-derived peptides

Windisch, M., Hutter‐Paier, B., Rockenstein, E. M., Hashimoto, M., Mallory, M. E., & Masliah, E. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0012-8 · Cited by 49

Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease

Bellucci, A., Navarria, L., Zaltieri, M., Missale, C., & Spano, P. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.031 · Cited by 49

Applying chaperones to protein-misfolding disorders: Molecular chaperones against α-synuclein in Parkinson's disease

Châari, A., Hoarau-Véchot, J., & Ladjimi, M. M. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.05.032 · Cited by 50

Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein

Xu, M., Ryan, P., Rudrawar, S., Quinn, R. J., Zhang, H., & Mellick, G. D. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0304-y · Cited by 49

Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans

Courtland, J. L., Bradshaw, T. W., Waitt, G., Soderblom, E. J., Ho, T., Rajab, A., Vancini, R., Kim, I. H., & Soderling, S. H. (2021) · eLife · doi:10.7554/elife.61590 · Cited by 49

Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms

Halliday, G. M., & McCann, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.006 · Cited by 48

Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils

Ishimaru, H., Casamenti, F., Uéda, K., Maruyama, Y., & Pepeu, G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02439-8 · Cited by 48

Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation

Pancoe, S. X., Wang, Y. J., Shimogawa, M., Perez, R. M., Giannakoulias, S. G., & Petersson, E. J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167859 · Cited by 44

δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP+ and/or hypoxia

Chen, T., Li, J., Chao, D., Sandhu, H. K., Liao, X., Zhao, J., Wen, G., & Xia, Y. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.022 · Cited by 47

Lipid dysfunction and pathogenesis of multiple system atrophy

Bleasel, J. M., Wong, J. H., Halliday, G. M., & Kim, W. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-15 · Cited by 47

Fibril Breaking Accelerates α-Synuclein Fibrillization

Shvadchak, V. V., Claessens, M. M. A. E., & Subramaniam, V. (2015) · The Journal of Physical Chemistry B · doi:10.1021/jp5111604 · Cited by 50

α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease?

Lee, S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603322110904 · Cited by 48

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

Chegão, A., Guarda, M., Alexandre, B. M., Shvachiy, L., Temido‐Ferreira, M., Marques-Morgado, I., Gomes, B. F., Matthiesen, R., Lopes, L. V., Florindo, P. R., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00314-x · Cited by 49

Hypergraph-regularized multimodal learning by graph diffusion for imaging genetics based Alzheimer’s Disease diagnosis

Wang, M., Shao, W., Huang, S., & Zhang, D. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102883 · Cited by 47

Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector–Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain

Svarcbahs, R., Julku, U. H., & Myöhänen, T. T. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2309-16.2016 · Cited by 49

The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity

Kim, H., Calatayud, C., Guha, S. K., Fernández‐Carasa, I., Berkowitz, L. A., Carballo‐Carbajal, I., Ezquerra, M., Fernández‐Santiago, R., Kapahi, P., Raya, Á., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0881-7 · Cited by 50

APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology

Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 45

Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders

Balana, A. T., & Pratt, M. R. (2021) · Biochemical Journal · doi:10.1042/bcj20200609 · Cited by 46

α-Synuclein-Induced Tubule Formation in Lipid Bilayers

Pandey, A. P., Haque, F., Rochet, J., & Hovis, J. S. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp1121917 · Cited by 44

Exploring Myelin Dysfunction in Multiple System Atrophy

Wong, J. H., Halliday, G. M., & Kim, W. S. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.337 · Cited by 45

Refolding of helical soluble α‐synuclein through transient interaction with lipid interfaces

Rovere, M., Sanderson, J. B., Fonseca‐Ornelas, L., Patel, D. S., & Bartels, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13047 · Cited by 46

Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins

Jain, M. K., Singh, P., Roy, S., & Bhat, R. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00343 · Cited by 46

Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease

Spencer, B. J., Trinh, I., Rockenstein, E. M., Mante, M., Florio, J. B., Adame, A., El‐Agnaf, O. M. A., Kim, C., Masliah, E., & Rissman, R. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.001 · Cited by 48

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils

Dhillon, J.-K. S., Trejo‐Lopez, J. A., Riffe, C. J., Levites, Y., Sacino, A. N., Borchelt, D., Yachnis, A. T., & Giasson, B. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0733-3 · Cited by 47

α-Synuclein, Lrrk2 and Their Interplay In Parkinson‘s Disease

Liu, G., Aliaga, L., & Cai, H. (2012) · Future Neurology · doi:10.2217/fnl.12.2 · Cited by 45

Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila

Balija, M. B. G., Griesinger, C., Herzig, A., Zweckstetter, M., & Jäckle, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024701 · Cited by 44

Linking New Paradigms in Protein Chemistry to Reversible Membrane-Protein Interactions

Halskau, Ø., Muga, A., & Martı́nez, A. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309788922199 · Cited by 44

A small-angle X-ray scattering study of alpha-synuclein from human red blood cells

Araki, K., Yagi, N., Nakatani, R., Sekiguchi, H., So, M., Yagi, H., Ohta, N., Nagai, Y., Goto, Y., & Mochizuki, H. (2016) · Scientific Reports · doi:10.1038/srep30473 · Cited by 45

Vibrational Circular Dichroism Reveals Supramolecular Chirality Inversion of α-Synuclein Peptide Assemblies upon Interactions with Anionic Membranes

Martial, B., Lefèvre, T., Buffeteau, T., & Auger, M. (2019) · ACS Nano · doi:10.1021/acsnano.8b08932 · Cited by 44

Alpha-Synuclein Expression in the Developing Human Brain

Raghavan, R., de Kruijff, L., Sterrenburg, M. D., Rogers, B. B., Hladik, C. L., & White, C. L. (2004) · Pediatric and Developmental Pathology · doi:10.1007/s10024-003-7080-9 · Cited by 42

Phosphorylated α‐synuclein in normal mouse brain

Hirai, Y., Fujita, S. C., Iwatsubo, T., & Hasegawa, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.046 · Cited by 45

α-Synuclein has structural and functional similarities to small heat shock proteins

Kim, T. D., Choi, E., Rhim, H., Paik, S. R., & Yang, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.208 · Cited by 44

Dementia with Lewy Bodies

Gómez‐Tortosa, E., Ingraham, A. O., Irizarry, M. C., & Hyman, B. T. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb06016.x · Cited by 44

α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases

So, R. W. L., & Watts, J. C. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168011 · Cited by 46

Two Different Binding Modes of α-Synuclein to Lipid Vesicles Depending on its Aggregation State

Högen, T., Levin, J., Schmidt, F., Caruana, M., Vassallo, N., Kretzschmar, H. A., Bötzel, K., Kamp, F., & Giese, A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.01.059 · Cited by 44

Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice

Casadei, N., Pöhler, A.-M., Tomás‐Zapico, C., Torres-Peraza, J. F., Schwedhelm, I., Witz, A., Zamolo, I., de Heer, R. C., Spruijt, B. M., Noldus, L. P. J. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt467 · Cited by 48

Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation

López, L., Varea, O., Navarro, S., Carrodeguas, J. A., de Groot, N. S., Ventura, S., & Sancho, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060964 · Cited by 43

Vaccination strategies in tauopathies and synucleinopathies

Braczynski, A. K., Schulz, J. B., & Bach, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14207 · Cited by 44

Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model

Taylor-Whiteley, T. R., Maitre, C. L. L., Duce, J. A., Dalton, C., & Smith, D. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038042 · Cited by 43

N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity

Vinueza‐Gavilanes, R., Íñigo-Marco, I., Larrea, L., Lasa, M., Carte, B., Santamaría, E., Fernández‐Irigoyen, J., Bugallo, R., Aragón, T., Aldabe, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104781 · Cited by 44

Amyloidogenic Intrinsically Disordered Proteins: New Insights into Their Self-Assembly and Their Interaction with Membranes

Scollo, F., & Rosa, C. L. (2020) · Life · doi:10.3390/life10080144 · Cited by 43

Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective

Knecht, L. H., Folke, J., Dodel, R. C., Ross, J. A., & Albus, A. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01288-7 · Cited by 44

Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro

Ono, K., Hirohata, M., & Yamada, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21271 · Cited by 43

α-Synuclein: A potent inducer of tau pathology

Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 45

Alpha-synuclein-immunoreactive deposits in human and animal prion diseases

Haı̈k, S., Privat, N., Adjou, K. T., Sazdovitch, V., Dormont, D., Duyckaerts, C. J., & Hauw, J. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0499-z · Cited by 43

Adult Astrogenesis and the Etiology of Cortical Neurodegeneration

Mohn, T. C., & Koob, A. O. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25520 · Cited by 44

E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity

Rovere, M., Powers, A. E., Jiang, H., Pitino, J. C., Fonseca‐Ornelas, L., Patel, D. S., Achille, A., Langen, R., Varkey, J., & Bartels, T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006551 · Cited by 42

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

Belloli, S., Morari, M., Murtaj, V., Valtorta, S., Moresco, R. M., & Gilardi, M. C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00152 · Cited by 43

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies

Rcom-H'cheo-Gauthier, A. N., Osborne, S. L., Meedeniya, A. C. B., & Pountney, D. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00570 · Cited by 42

Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells

Li, W.-J., Jiang, H., Song, N., & Xie, J.-X. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-1117-7 · Cited by 41

Characterization of fibrillation process of α-synuclein at the initial stage

Tashiro, M., Kojima, M., Kihara, H., Kasai, K., Kamiyoshihara, T., Uéda, K., & Shimotakahara, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.127 · Cited by 41

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats

Shin, M., Kim, T.-W., Lee, J. M., Ji, E., & Lim, B. (2017) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1734906.453 · Cited by 41

α-Synuclein nonhuman primate models of Parkinson’s disease

Marmion, D. J., & Kordower, J. H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1720-0 · Cited by 44

Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form

Collier, T. J., Srivastava, K. R., Justman, C. J., Grammatopoulous, T., Hutter‐Paier, B., Prokesch, M., Havas, D., Rochet, J., Liu, F., Jock, K., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.007 · Cited by 41

Alpha-synuclein fragments trigger distinct aggregation pathways

Chakroun, T., Evsyukov, V., Nykänen, N.-P., Höllerhage, M., Schmidt, A., Kamp, F., Ruf, V., Wurst, W., Rösler, T. W., & Höglinger, G. U. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2285-7 · Cited by 41

The Role of Synaptic Proteins in Alzheimer's Disease

Masliah, E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05562.x · Cited by 39

Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice

Maskri, L., Zhu, X., Fritzen, S., Kühn, K., Ullmer, C., Engels, P., Andriske, M., Stichel, C. C., & Lübbert, H. (2004) · Neurodegenerative Diseases · doi:10.1159/000085064 · Cited by 41

Pharmacogenetic studies of alcohol self-administration and withdrawal

Crabbe, J. C., & Phillips, T. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1608-6 · Cited by 40

A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson’s disease

Zhao, H., Li, F., Wang, Z., Wang, X., & Feng, T. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2485-1 · Cited by 41

Progress in the clinical and molecular genetics of familial parkinsonism

Kitada, T., Asakawa, S., Matsumine, H., Hattori, N., Shimura, H., Minoshima, S., Shimizu, N., & Mizuno, Y. (2000) · Neurogenetics · doi:10.1007/s100489900083 · Cited by 41

Accumulation of NACP/alpha -synuclein in Lewy body disease and multiple system atrophy

Shoji, M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.605 · Cited by 41

The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease

Yú, L., Zhong, G., Ren, M., Sun, T., Li, Y., Ye, M., Ma, C., Guo, Y., & Liu, C. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08755-0 · Cited by 42

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?

Greggio, E., Bisaglia, M., Civiero, L., & Bubacco, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-6 · Cited by 43

Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell Models

Xin, W., Emadi, S., Williams, S. M., Liu, Q., Schulz, P., He, P., Alam, N. B., Wu, J., & Sierks, M. R. (2015) · Biomolecules · doi:10.3390/biom5031634 · Cited by 40

Dioleoyl‐phosphatidic acid selectively binds to α‐synuclein and strongly induces its aggregation

Mizuno, S., Sasai, H., Kume, A., Takahashi, D., Satoh, M., Kado, S., & Sakane, F. (2017) · FEBS Letters · doi:10.1002/1873-3468.12592 · Cited by 42

Room-temperature in-cell EPR spectroscopy: alpha-Synuclein disease variants remain intrinsically disordered in the cell

Cattani, J., Subramaniam, V., & Drescher, M. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp03432f · Cited by 40

Proteasome Activation to Combat Proteotoxicity

Jones, C. L., & Tepe, J. J. (2019) · Molecules · doi:10.3390/molecules24152841 · Cited by 43

The Evolution-Driven Signature of Parkinson’s Disease

Diederich, N. J., Uchihara, T., Grillner, S. E., & Goetz, C. G. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.001 · Cited by 39

Influence of Lipid Membranes on α-Synuclein Aggregation

Kurochka, A. S., Yushchenko, D. A., Bouř, P., & Shvadchak, V. V. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00819 · Cited by 39

Fish Synucleins: An Update

Toni, M., & Cioni, C. (2015) · Marine Drugs · doi:10.3390/md13116665 · Cited by 40

Generation of reactive oxygen species and activation of NF‐κB by non‐Aβ component of Alzheimer's disease amyloid

Tanaka, S., Takehashi, M., Matoh, N., Iida, S., Suzuki, T. W., Futaki, S., Hamada, H., Masliah, E., Sugiura, Y., & Ueda, K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00958.x · Cited by 40

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

Wang, Z.-Y., Han, Z.-M., Liu, Q.-F., Tang, W., Ye, K., & Yao, Y.-Y. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000447 · Cited by 39

Structural Insights of Fe3+ Induced α-synuclein Fibrillation in Parkinson’s Disease

Zhao, Q., Tao, Y., Zhao, K., Ma, Y., Xu, Q., Liu, C., Zhang, S., & Li, D. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167680 · Cited by 39

Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease

Долгачева, Л. П., Зинченко, В. П., & Goncharov, N. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113043 · Cited by 43

A New Method for Quantitative Immunoblotting of Endogenous α-Synuclein

Newman, A. J., Selkoe, D. J., & Dettmer, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081314 · Cited by 38

Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson’s Disease

Werner, T., Horváth, I., & Wittung-Stafshede, P. E. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202085 · Cited by 40

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau

Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · Biology · doi:10.3390/biology9060122 · Cited by 44

α-Synuclein Fission Yeast Model: Concentration-Dependent Aggregation Without Plasma Membrane Localization or Toxicity

Brandis, K. A., Holmes, I. F., England, S. J., Sharma, N., Kukreja, L., & DebBurman, S. K. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:2:179 · Cited by 38

Occurrence of a-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex

Sebeo, J., Hof, P. R., & Perl, D. P. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0840-4 · Cited by 39

α-Synuclein Inclusions in Alzheimer and Lewy Body Diseases

Mukaetova‐Ladinska, E. B., Hurt, J., Jakes, R., Xuereb, J. H., Honer, W. G., & Wischik, C. M. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.5.408 · Cited by 39

Dopamine facilitates α-synuclein oligomerization in human neuroblastoma SH-SY5Y cells

Yamakawa, K., Izumi, Y., Takeuchi, H., Yamamoto, N., Kume, T., Akaike, A., Takahashi, R., Shimohama, S., & Sawada, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.015 · Cited by 38

Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies

Henderson, M. X., Chung, C. H.-Y., Riddle, D. M., Zhang, B., Gathagan, R. J., Seeholzer, S. H., Trojanowski, J. Q., & Lee, V. M. ‐. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2705-16.2017 · Cited by 39

Autophagy–lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease

Adams, J. L., Feuerborn, M., Molina, J. A., Wilden, A. R., Adhikari, B., Budden, T., & Lee, S. Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36379-z · Cited by 39

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 41

α‐Synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII

Liu, S., Fà, M., Ninan, I., Trinchese, F., Dauer, W. T., & Arancio, O. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05569.x · Cited by 38

α-Synuclein, Aβ and Alzheimer's disease

Wirths, O. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 37

Synucleins and their relationship to Parkinson’s disease

Halbach, O. V. B. U. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0921-7 · Cited by 37

The native form of α-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls

Jakowec, M. W., Petzinger, G. M., Sastry, S., Donaldson, D. M., McCormack, A., & Langston, J. W. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00599-0 · Cited by 38

Neuritic Alterations and Neural System Dysfunction in Alzheimer's Disease and Dementia with Lewy Bodies

Klucken, J., McLean, P. J., Gómez‐Tortosa, E., Ingelsson, M., & Hyman, B. T. (2003) · Neurochemical Research · doi:10.1023/a:1026061021946 · Cited by 38

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205

The Non-Amyloid-β Component of Alzheimer’s Disease Plaque Amyloid: Comparative Analysis Suggests a Normal Function as a Synaptic Plasticizer

George, J. M., & Clayton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_16 · Cited by 3

Properties of NACP/α-synuclein and its role in Alzheimer’s disease

Iwai, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00036-3 · Cited by 78

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51